• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hemogenyx Pharmaceuticals Plc. (OP:HOPHF)

2.330 UNCHANGED
Last Price Updated: 12:20 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hemogenyx Pharmaceuticals Plc.

< Previous 1 2 3 Next >
News headline image
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
February 23, 2026
Via ACCESS Newswire
News headline image
CORRECTION FROM SOURCE: Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
February 10, 2026
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
February 10, 2026
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Update on Admission of Shares
December 22, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC - Issue of Equity
December 18, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC - Second Patient Passes Initial Safety Tests
June 03, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Publication of Prospectus
November 19, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Clinical Trial Update and Grant of Share Awards
October 29, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Clearance to Initiate Pediatric Enrolment
October 06, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Half-year Report
September 30, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Signs Letter of Intent
September 23, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Third Patient Safety
September 17, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Invitation to Participate at DCNY Summit
September 11, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Manufacturing Partnership with Made Scientific
September 08, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
September 05, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Exercise of Warrants and Issue of Equity
September 03, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes
September 01, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Result of Audit Tender
August 29, 2025
Via ACCESS Newswire
News headline image
Hemogenyx raises £570,000 and Director's Dealing
August 26, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC - Third Patient Treated with HG-CT-1 CAR-T Therapy
August 15, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £250,000 and Director's Dealing
July 29, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Awarded Grant
July 16, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Clearance to Proceed with Pediatric Expansion
June 17, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director's Dealing
June 03, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Pediatric Amendment to Clinical Protocol
May 14, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Placing to Raise £451,250 and Director’s Dealing
May 08, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Second Patient Treated with HG-CT-1 CAR-T Therapy
May 02, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Final Results
April 28, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces FDA Annual Report
April 03, 2025
Via ACCESS Newswire
News headline image
Hemogenyx Pharmaceuticals PLC Announces Total Voting Rights
March 31, 2025
Via ACCESS Newswire
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap